Why the study?
Vascular and bleeding complications related to secondary femoral access site are frequent in patients undergoing TAVR and associate with poorer outcomes.
Do vascular closure devices (VCDs) reduce vascular and bleeding complications for secondary femoral access hemostasis in patients undergoing TAVR?
Do vascular closure devices (VCDs) reduce vascular and bleeding complications for secondary femoral access hemostasis in patients undergoing TAVR?
Answers are grounded in this paper and cite their sources.
VCDs for secondary femoral access in TAVR merit prospective evaluation; leaves open whether they meaningfully reduce complications.
Vascular and bleeding complications related to secondary femoral access site are frequent in patients undergoing TAVR, and their occurrence is associated to poorer outcomes. We aimed to evaluate the clinical impact of VCDs for secondary femoral access hemostasis in TAVR procedures.
No takes yet. Share an insight, caveat, or question.
Junquera et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: